Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123390022 | 12339002 | 2 | F | 20160802 | 20160505 | 20160822 | PER | US-PFIZER INC-2016240817 | PFIZER | 78.00 | YR | F | Y | 57.00000 | KG | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123390022 | 12339002 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | UNK, 1X/DAY | U | 4782 | TABLET | QD | |||||||
| 123390022 | 12339002 | 2 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0.625 UNK, UNK | U | 4782 | TABLET | ||||||||
| 123390022 | 12339002 | 3 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | UNK, ALTERNATE DAY | U | 4782 | TABLET | QOD | |||||||
| 123390022 | 12339002 | 4 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | UNK, EVERY THREE DAY | U | 4782 | TABLET | ||||||||
| 123390022 | 12339002 | 5 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0.625 MG, 1X/DAY | U | 4782 | .625 | MG | TABLET | QD | ||||||
| 123390022 | 12339002 | 6 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | |||||||||||
| 123390022 | 12339002 | 7 | C | NIFEDICAL XL | NIFEDIPINE | 1 | UNK | 0 | |||||||||||
| 123390022 | 12339002 | 8 | C | XALATAN | LATANOPROST | 1 | 1 GTT, 1X/DAY (EYE DROP ONCE AT NIGHT) | 0 | 1 | GTT | EYE DROPS | QD | |||||||
| 123390022 | 12339002 | 9 | C | XALATAN | LATANOPROST | 1 | UNK | 0 | EYE DROPS | ||||||||||
| 123390022 | 12339002 | 10 | C | ZOCOR | SIMVASTATIN | 1 | UNK | 0 | |||||||||||
| 123390022 | 12339002 | 11 | C | NEURONTIN | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 123390022 | 12339002 | 12 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK, 1X/DAY (ONE LOW DOSE AT NIGHT) | 0 | QD | ||||||||||
| 123390022 | 12339002 | 13 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 123390022 | 12339002 | 14 | C | ALEVE | NAPROXEN SODIUM | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 123390022 | 12339002 | 15 | C | ALEVE | NAPROXEN SODIUM | 1 | UNK | 0 | |||||||||||
| 123390022 | 12339002 | 16 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123390022 | 12339002 | 1 | Hot flush |
| 123390022 | 12339002 | 6 | Hypertension |
| 123390022 | 12339002 | 10 | Blood cholesterol abnormal |
| 123390022 | 12339002 | 11 | Back disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123390022 | 12339002 | Burning sensation | |
| 123390022 | 12339002 | Drug effect incomplete | |
| 123390022 | 12339002 | Feeling abnormal | |
| 123390022 | 12339002 | Intentional product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123390022 | 12339002 | 11 | 201512 | 0 |